---
title: "VK2735 in Chronic weight management: Effect on quality measures"
description: "Formulary evidence on VK2735 in Chronic weight management: Effect on quality measures. Topics: Merit-based Incentive Payment System 2026 measure 128: body mass index screening and follow-up plan, Healthy People 2030 objective NWS-03: proportion of adults with obesity, and Obesity quality measures in federal reporting and payment programs. 3 evidence topics quoted from 3 sources."
canonical: "https://www.evicenter.com/drugs/vk2735--chronic-weight-management/product-information-and-disease-description/effect-on-quality-measures"
published: "2026-11-15T21:45:47-05:00"
modified: "2026-11-15T21:45:47-05:00"
---

# VK2735 in Chronic weight management: Effect on quality measures

<a id="heading-2.1.2.13"></a>

## 2.1.2.13 Effect of VK2735 on Quality Measures

<a id="topic-2.1.2.13-1"></a>

### Product-specific effect on quality measures

No evidence found.

<a id="topic-2.1.2.13-2"></a>

### Merit-based Incentive Payment System 2026 measure 128: body mass index screening and follow-up plan

> “Percentage of patients aged 18 years and older with a BMI documented during the current encounter or within the previous twelve months AND who had a follow-up plan documented if the most recent BMI was outside of normal parameters.”
> “Proposed outline of treatment to be conducted as a result of a BMI outside of normal parameters.”
> “Pharmacological interventions”
> “This measure specification is only available for MIPS Value Pathway (MVP) reporting and is not available for traditional MIPS reporting.”

Source: [CMS Quality Payment Program measure 128 (2026)](https://qpp.cms.gov/docs/QPP_quality_measure_specifications/CQM-Measures/2026_Measure_128_MIPSCQM.pdf)

<a id="topic-2.1.2.13-3"></a>

### Healthy People 2030 objective NWS-03: proportion of adults with obesity

| Field | Objective record |
| --- | --- |
| Objective | “Reduce the proportion of adults with obesity” |
| National baseline | “38.6” |
| National baseline definition | “percent of adults aged 20 years and over had obesity in 2013-16” |
| Most recent data | “40.2” |
| Most recent data period | “(2021-23)” |
| National target | “36.0” |
| National status | “Little or no detectable change” |
| Desired direction | “Decrease desired” |
| Data source | “National Health and Nutrition Examination Survey (NHANES), CDC/NCHS” |

Source: [ODPHP Healthy People 2030 NWS-03](https://odphp.health.gov/healthypeople/objectives-and-data/browse-objectives/overweight-and-obesity/reduce-proportion-adults-obesity-nws-03)

<a id="topic-2.1.2.13-4"></a>

### Obesity quality measures in federal reporting and payment programs

> “Obesity quality measures have entered various stages of testing and development, but only a select few are included in reporting and payment programs.”
> “One process measure for adults, "Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan" is used in Medicare.”
> “No outcome or digital quality measure exists for the disease of obesity.”
> “The general absence of quality measures for obesity means that there are no objective measures to address the quality of obesity care or its outcome.”

Source: [Zvenyach and Pickering (2023)](https://pubmed.ncbi.nlm.nih.gov/37651080/)

## Related pages
- [VK2735: Chronic weight management](https://www.evicenter.com/drugs/vk2735--chronic-weight-management) · [Markdown](https://www.evicenter.com/drugs/vk2735--chronic-weight-management.md)
- [VK2735 in Chronic weight management: Terms and abbreviations](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/terms-and-abbreviations) · [Markdown](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/terms-and-abbreviations.md)
- [VK2735: Chronic weight management](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/executive-summary) · [Markdown](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/executive-summary.md)
- [VK2735 in Chronic weight management: Product information and disease description](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/product-information-and-disease-description) · [Markdown](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/product-information-and-disease-description.md)
- [VK2735 in Chronic weight management: Clinical evidence](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/clinical-evidence) · [Markdown](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/clinical-evidence.md)
- [VK2735 in Chronic weight management: Economic information and modeling report](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/economics) · [Markdown](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/economics.md)
- [VK2735 in Chronic weight management: References](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/references) · [Markdown](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/references.md)
